APA (7th ed.) Citation

H, H., C, R., E, J., S, N., S, H., S, S., . . . T, B. (2026). A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study). Palliative medicine, 40(6), 856. https://doi.org/10.1177/02692163261428947

Chicago Style (17th ed.) Citation

H, Hirschinger, et al. "A Randomized Controlled Clinical Trial of Intranasal Versus Subcutaneous Midazolam for Agitation in Terminal Illness (MinTU Study)." Palliative Medicine 40, no. 6 (2026): 856. https://doi.org/10.1177/02692163261428947.

MLA (9th ed.) Citation

H, Hirschinger, et al. "A Randomized Controlled Clinical Trial of Intranasal Versus Subcutaneous Midazolam for Agitation in Terminal Illness (MinTU Study)." Palliative Medicine, vol. 40, no. 6, 2026, p. 856, https://doi.org/10.1177/02692163261428947.